ORIX USA Launches ORIX USA Health and Life Sciences LLC with CEO John Amos at the Helm

Updated

ORIX USA Launches ORIX USA Health and Life Sciences LLC with CEO John Amos at the Helm

DALLAS--(BUSINESS WIRE)-- ORIX USA has created a new business unit specializing in the healthcare and life sciences sectors; seasoned industry veteran John Amos has joined ORIX Health and Life Sciences as CEO.

ORIX Health and Life Sciences will invest in operating companies within the sector and stimulate the growth of the companies through acquisitions, capital and operating assistance from ORIX USA.


ORIX USA is a Dallas, Texas-based diversified financial conglomerate with both direct investment portfolios and ownership of operating subsidiaries in investment banking (Houlihan Lokey), multifamily mortgage lending (RED Capital Group) and asset management (Mariner Investment Group). With Health and Life Sciences, ORIX USA will expand its portfolio of operating companies into healthcare, a large and growing sector of the economy.

"As with previous acquisitions including Houlihan Lokey, RED Capital Group and Mariner Investment Group, our interest is in businesses with strong management teams, which will be maintained as separate entities under ORIX USA's governance and supported by our investment capital," said ORIX USA CEO Jim Thompson. "With the launch of ORIX USA Health and Life Sciences, this strategy is broadening from financial firms to the healthcare sector."

CEO John Amos has a strong background in operating health care companies having worked at both McKesson and Bristol Meyer. As CEO of Oncology Therapeutic Networks (OTN), Amos grew OTN through a string of successfully executed acquisitions before selling it to McKesson Corporation. Amos also has served on the boards of Apollo Health Street, Prodigy Health, Navigating Cancer, CITIC Pharmaceuticals, Aesyntix Health and as the venture partner for Bioveda China Fund.

About ORIX USA

ORIX USA is a diversified financial company with more than $5 billion of assets in sectors spanning commercial finance, venture finance, commercial real estate, mortgage backed securities and public finance. Operating subsidiaries include Houlihan Lokey, Mariner Investment Group and RED Capital Group. Headquartered in Dallas Texas, ORIX USA and its subsidiaries have approximately 1,400 employees, $25 billion of assets managed for others and offices in most major cities including New York, Los Angeles, Milwaukee, Atlanta as well as Hong Kong and Tokyo.

ORIX USA Corporation is a wholly owned subsidiary of ORIX Corporation, a publicly traded international diversified financial services firm headquartered in Tokyo, listed on the Tokyo (8591) and New York (NYS: IX) stock exchanges with operations in over 27 countries worldwide.



C. Pharr & Company for ORIX USA
Shelby Menczer, 972-931-7576 x 353
Shelby@pharrpr.com

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS:

The article ORIX USA Launches ORIX USA Health and Life Sciences LLC with CEO John Amos at the Helm originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement